Health Canada10 Apr 2026
Apo-Fluoxetine: The impurities are out of specification and out of trend
Health Canada published a recall notice for Apo-Fluoxetine: The impurities are out of specification and out of trend on 10 Apr 2026. It is one of 311 notices of this kind from Health Canada since 2 Apr 2026 in AreaZine's record.
Recall
The recall notice
- Issued by
- Health Canada
- Issued
- 10 Apr 2026
- Recall type
- Health product recall
- Companies
- Apotex Inc. · 150 Signet Drive · Toronto ON · M9L 1T9
- Official source
- Health Canada: the notice at its source
The latest from Health CanadaEvery warning and recall in Canada
Source: Health Canada: the notice at its source. AreaZine rebuilds this page from the agency's record; the agency's page is the one to act on. Contains information licensed under the Open Government Licence – Canada.
The notice as issued
Issue: The impurities are out of specification and out of trend in the affected lot. What you should do What to do: Verify if your product is affected. Consult your healthcare provider prior to discontinuing use of the affected product(s), or for any health concerns. Contact the recalling firm if you have any questions about the recall. Report any health product related side effects to Health Canada. Report any other health product safety complaints to Health Canada. Additional information Background Affected products: Brand Product Name Market Authorization Dosage Form Strength Lot Apotex Apo-Fluoxetine 20mg DIN 02216361 Capsule Fluoxetine (Fluoxetine hydrochloride) 20mg VM4608, VM4612 Apotex Apo-Fluoxetine 10mg DIN 02216353 Capsule Fluoxetine (Fluoxetine hydrochloride) 10mg VM4598 Issue
Source: Health Canada: the notice at its source. The text is the agency's, unedited. Contains information licensed under the Open Government Licence – Canada.